mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis

  • Authors:
    • Xiansen Zhang
    • Jing Xie
    • Changfa Yu
    • Lixia Yan
    • Zeshan Yang
  • View Affiliations

  • Published online on: November 19, 2013     https://doi.org/10.3892/etm.2013.1417
  • Pages: 360-364
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To evaluate the clinical significance of mRNA expression of cytokeratin 19 (CK19), epidermal growth factor receptor (EGFR) and lung‑specific X protein (LUNX), a total of 42 patients who were diagnosed with non‑small cell lung cancer (NSCLC) by pathology were studied retrospectively. The messenger RNA (mRNA) expres­sion levels of CK19, EGFR and LUNX in the peripheral blood were analyzed using reverse transcription‑polymerase chain reaction (RT‑PCR). The expression of CK19 mRNA did not differ significantly according to the location, size, clinical stage or differentiation of the primary tumor (all P>0.05). However, there was a significant difference in the level of CK19 mRNA expression between squamous carcinoma and adenocarcinoma. The positive rates of EGFR mRNA in the patient and the healthy control groups were 69.0 and 12.5%, respectively, and were significantly different (P<0.05). The positive rates of LUNX mRNA in the two groups were 40.5 and 0%, respectively, and were significantly different (P<0.05). The results indicate that the mRNA expression of CK19, EGFR and LUNX in the peripheral blood is of significant clinical value for the diagnosis of micrometastasis and the prognosis of lung cancer.
View Figures
View References

Related Articles

Journal Cover

2014-February
Volume 7 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang X, Xie J, Yu C, Yan L and Yang Z: mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis. Exp Ther Med 7: 360-364, 2014.
APA
Zhang, X., Xie, J., Yu, C., Yan, L., & Yang, Z. (2014). mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis. Experimental and Therapeutic Medicine, 7, 360-364. https://doi.org/10.3892/etm.2013.1417
MLA
Zhang, X., Xie, J., Yu, C., Yan, L., Yang, Z."mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis". Experimental and Therapeutic Medicine 7.2 (2014): 360-364.
Chicago
Zhang, X., Xie, J., Yu, C., Yan, L., Yang, Z."mRNA expression of CK19, EGFR and LUNX in patients with lung cancer micrometastasis". Experimental and Therapeutic Medicine 7, no. 2 (2014): 360-364. https://doi.org/10.3892/etm.2013.1417